Elan (ELN) is a neuroscience-based biotechnology company. Elan is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases and in realizing the potential of its scientific discoveries and drug delivery technologies. This stock is trading down 0.39% at $12.88 in recent trading after hitting a 52-week high of $13.01 earlier in the day.
Today's Range: $12.73-$13.0152-Week Range: $5.59-$12.93 Volume: 1.3 million Three-Month Average Volume: 2.8 million Elan has a market cap of $7.60 billion and an enterprise value of $7.87 billion. The stock trades at a trailing price-to-earnings of 11.86 and a forward price-to-earnings of 107.67. Its estimated growth rate for this year is 317%, and for next year it's pegged at -90.2%. The current short interest as a percentage of the float for Elan is very low at 1.2%. From a technical standpoint, ELN broke out recently above some past overhead resistance at $12.20 and then $12.60 on monster volume. Market players should continue to look for long biased trades in ELN as long as the stock can remain above $12.60 on a closing basis. The next significant overhead resistance level won't come into play until ELN hits $14. To see more stocks hitting new 52-week highs today, check out the Stocks Hitting New 52-Week Highs portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.
Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV